WebMar 25, 2024 · BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environment. The company was founded by … WebMar 14, 2024 · During the fourth quarter of the prior fiscal year, the comparable non-GAAP net loss was $3.4 million, or $0.03 per share. Total operating expenses for the fiscal year ended January 31, 2024 were ...
Buy BioPharmX Stock BPMX Stock Price Today & News
WebBio-Rad Laboratories Inc. - Ordinary Shares - Class A (BIO) Stock Price Today, News, Quotes, FAQs and Fundamentals. Trending. 32.27%. JNJ 4.13%. BFRG 20.93%. WebWOODCLIFF LAKE - Timber Pharmaceuticals, Inc. , (NYSE American: TMBR), formerly known as BioPharmX Corporation ('Timber' or the 'Company'), a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced that its merger with Timber Pharmaceuticals LLC . current app bank name
BioPharmX : Reports Positive Topline Results of BPX-01 Topical ...
WebSome drug abuse treatments are a month long, but many can last weeks longer. Some drug abuse rehabs can last six months or longer. At Your First Step, we can help you to find 1 … WebApr 27, 2024 · --BioPharmX Corporation today announced that the date of its special stockholders' meeting to consider and vote on the proposed merger of BioPharmX with Timber Pharmaceuticals LLC and related ... WebDec 26, 2024 · The latest Tweets from Biopharm Alpha (@BiopharmAlpha). Biopharmaceutical industry news and insights Not investment advice DYODD 🧬🧫🔬🧪🦠 current apex legends shop